Unraveling heterogeneity within ACPA-negative rheumatoid arthritis; the subgroup of patients with a strong clinical and serological response to initiation of DMARD-treatment favor disease resolution

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: M. Verstappen, H.W. van Steenbergen, P.H.P. de Jong, A.H.M. van der Helm-van Mil

Journal title: Arthritis Research & Therapy

Journal publisher: BioMed Central

Published year: 2022

DOI identifier: 10.1186/s13075-021-02671-z

ISSN: 1478-6354